Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 10, 2024

BUY
$25.89 - $29.73 $342,809 - $393,654
13,241 Added 50.44%
39,494 $1.1 Million
Q4 2023

Jan 11, 2024

SELL
$26.13 - $33.94 $4,050 - $5,260
-155 Reduced 0.59%
26,253 $756,000
Q3 2023

Oct 12, 2023

BUY
$32.09 - $37.51 $847,432 - $990,564
26,408 New
26,408 $876,000
Q1 2023

Apr 10, 2023

SELL
$39.39 - $51.28 $585,177 - $761,815
-14,856 Reduced 55.12%
12,095 $493,000
Q4 2022

Jan 10, 2023

BUY
$41.75 - $54.5 $334 - $436
8 Added 0.03%
26,951 $1.38 Million
Q3 2022

Oct 07, 2022

BUY
$43.76 - $53.42 $24,680 - $30,128
564 Added 2.14%
26,943 $1.18 Million
Q2 2022

Jul 29, 2022

BUY
$46.53 - $55.17 $21,031 - $24,936
452 Added 1.74%
26,379 $1.38 Million
Q1 2022

Apr 28, 2022

SELL
$45.75 - $56.69 $95,343 - $118,141
-2,084 Reduced 7.44%
25,927 $1.34 Million
Q4 2021

Jan 18, 2022

BUY
$41.32 - $61.25 $79,788 - $118,273
1,931 Added 7.4%
28,011 $1.65 Million
Q3 2021

Oct 25, 2021

BUY
$39.25 - $50.42 $41,094 - $52,789
1,047 Added 4.18%
26,080 $1.12 Million
Q2 2021

Jul 21, 2021

BUY
$35.91 - $40.68 $7,217 - $8,176
201 Added 0.81%
25,033 $980,000
Q1 2021

Apr 28, 2021

BUY
$33.49 - $37.77 $19,156 - $21,604
572 Added 2.36%
24,832 $900,000
Q4 2020

Jan 21, 2021

SELL
$33.47 - $42.56 $7,095 - $9,022
-212 Reduced 0.87%
24,260 $893,000
Q3 2020

Oct 23, 2020

SELL
$31.75 - $37.25 $249,999 - $293,306
-7,874 Reduced 24.34%
24,472 $898,000
Q2 2020

Jul 21, 2020

BUY
$30.12 - $36.54 $7,409 - $8,988
246 Added 0.77%
32,346 $1.06 Million
Q1 2020

Apr 10, 2020

BUY
$27.03 - $38.62 $867,663 - $1.24 Million
32,100 New
32,100 $1.05 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bcs Wealth Management Portfolio

Follow Bcs Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bcs Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Bcs Wealth Management with notifications on news.